$AMIH Appoints Original “Shark Tank” Investor Kevin

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
176
$AMIH Appoints Original “Shark Tank” Investor Kevin Harrington to its Advisory Board;

With 40 Year Track Record, Harrington has Produced over $5 Billion in Global Sales, Launched over 500 Products

Addison, TX, March 18, 2021 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), a diversified holding company dedicated to acquiring and operating health, wellness, infrastructure and technology companies, today announced that iconic businessman, veteran entrepreneur and inaugural “Shark Tank” investor Kevin Harrington has joined its newly formed Advisory Board.

In that role, Mr. Harrington will serve for a two-year term as the Company’s Brand Ambassador and Advisor on marketing, promotions, acquisitions, licensing and all other sales and growth initiatives.

Mr. Harrington is widely known for being an original “Shark” investor on the ABC television hit series “Shark Tank.” He has launched over 20 businesses that have grown to over $100 million in sales each. He has launched over 500 products generating more than $5 billion in sales worldwide with iconic brands and celebrities such as Jack LaLanne, Tony Little and George Foreman.

“I consider it a privilege to be a part of AMIH, and to contribute to its mission of revolutionizing healthcare and wellness for main street America,” Mr. Harrington stated and added, “I am eagerly looking forward to rolling up my sleeves and helping foster its growth and to promote its brands to new levels of success.”

Commenting on Mr. Harrington’s appointment to the Company’s newly formed Advisory Board, AMIH Chief Executive Officer, Jacob Cohen, said, “We’re thrilled. Kevin is a legendary entrepreneur with expertise and connections that I’m confident will accelerate our growth exponentially over the next couple years.

“Not only has Kevin agreed to provide endorsements, appearances and other assets to promote our products and services, but I expect his advisory services will be vital to our business development, marketing, acquisitions and other growth initiatives,” Mr. Cohen stated and continued, “Kevin will be a truly world class asset and addition to our Advisory Board.”

Additional information regarding Mr. Harrington’s appointment is included in the Current Report on Form 8-K which the Company is filing today with the Securities and Exchange Commission. The Advisory Board’s mandate is to provide guidance to the Board of Directors regarding business development, marketing, acquisitions, other strategic initiatives and other matters as may be requested.

About Kevin Harrington
Through his entrepreneurial experiences, Kevin realized his talent for turning underutilized assets into growth opportunities. While watching late-night television, he realized nothing was being broadcast on the Discovery Channel after normal broadcast hours. He seized the opportunity to launch what later came to be called the infomercial. Before long, he had helped make, “but wait, there’s more,” part of our cultural history. He’s launched massively successful products like The Food Saver, Ginsu Knives, The Great Wok of China, The Flying Lure, and many more.

He has worked with amazing celebrities like Billie Mays, Tony Little, Jack Lalanne, and George Foreman to name a few. Kevin then built on that success to help pioneer the As Seen on TV brand. After empowering others to achieve success, he recognized the shifting marketplace trends and began to intentionally build his personal brand.

His platform-building efforts earned him a seat as an original “shark” on the hit TV show Shark Tank, where he continued to live out his passion -- empowering entrepreneurs to greatness. As a business shark, Kevin knows how to disrupt the marketplace and orchestrate a killer investment deal, bring the best resources to the table and build thriving businesses from scratch. But his people-first, win-win perspective is at the heart of everything.

Like his sales mentor, Zig Ziglar said, “You can have everything in life you want, if you will just help enough other people get what they want.” Kevin’s been called The Entrepreneur’s Entrepreneur and the Entrepreneur Answer Man, because he knows the challenges unique to start-ups and has a special passion for helping entrepreneurs succeed.

About American International Holdings Corporation
American International Holdings Corp. is a diversified holding company dedicated to (a) acquiring, managing and operating health, wellness, infrastructure and technology companies, businesses and/or brands located both in the United States and abroad; (b) operating and managing an online platform providing customers with access to life and career coaches through LifeGuru, Inc. (www.LifeGuru.me); and (c) operating and managing an online telemedicine platform connecting customers to board certified physicians and licensed mental and behavioral health counselors through ZipDoctor, Inc. (www.ZipDoctor.co). The Company seeks opportunities to acquire and grow businesses that possess strong brand values and that can generate long-term sustainable free cash flow and attractive returns in order to maximize value for the Company and its stakeholders.

FORWARD-LOOKING STATEMENTS: This press release may contain forward-looking statements, including information about management’s view of the Company’s future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. These risk factors and others are included from time to time in filings made by the Company with the Securities and Exchange Commission, including, but not limited to, in the “Risk Factors” sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Investors Relations Contact:
Frank Benedetto
(619) 915-9422
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading